A citation-based method for searching scientific literature

Stephen W Duffy, Amanda Dibden, Dimitrios Michalopoulos, Judith Offman, Dharmishta Parmar, Jacquie Jenkins, Beverley Collins, Tony Robson, Suzanne Scorfield, Kathryn Green, Clare Hall, Xiao-Hui Liao, Michael Ryan, Fiona Johnson, Guy Stevens, Olive Kearins, Sarah Sellars, Julietta Patnick. Lancet Oncol 2016
Times Cited: 76







List of co-cited articles
492 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
325
26


Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
Kevin C Oeffinger, Elizabeth T H Fontham, Ruth Etzioni, Abbe Herzig, James S Michaelson, Ya-Chen Tina Shih, Louise C Walter, Timothy R Church, Christopher R Flowers, Samuel J LaMonte,[...]. JAMA 2015
797
19

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
323
19


Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
Yasuaki Sagara, Melissa Anne Mallory, Stephanie Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. JAMA Surg 2015
109
17

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
444
15

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
487
15

Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.
Donella Puliti, Stephen W Duffy, Guido Miccinesi, Harry de Koning, Elsebeth Lynge, Marco Zappa, Eugenio Paci. J Med Screen 2012
256
15

Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
H Gilbert Welch, Philip C Prorok, A James O'Malley, Barnett S Kramer. N Engl J Med 2016
301
15

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
196
14


A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
318
14

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
185
13


Characterizing the impact of 25 years of DCIS treatment.
Elissa M Ozanne, Yiwey Shieh, James Barnes, Colleen Bouzan, E Shelley Hwang, Laura J Esserman. Breast Cancer Res Treat 2011
71
12

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
138
11

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
225
11

Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
László Tabár, Bedrich Vitak, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Anders Cohen, Tibor Tot, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, Jean Ching-Yuan Fann, Johan Rosell,[...]. Radiology 2011
412
11

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
173
11

Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.
Sue M Moss, Christopher Wale, Robert Smith, Andrew Evans, Howard Cuckle, Stephen W Duffy. Lancet Oncol 2015
99
10


Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
Stephen W Duffy, Olorunsola Agbaje, Laszlo Tabar, Bedrich Vitak, Nils Bjurstam, Lena Björneld, Jonathan P Myles, Jane Warwick. Breast Cancer Res 2005
130
10

The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
214
10

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Lawrence J Solin, Robert Gray, Lorie L Hughes, William C Wood, Mary Ann Lowen, Sunil S Badve, Frederick L Baehner, James N Ingle, Edith A Perez, Abram Recht,[...]. J Clin Oncol 2015
158
10

Breast-cancer screening--viewpoint of the IARC Working Group.
Béatrice Lauby-Secretan, Chiara Scoccianti, Dana Loomis, Lamia Benbrahim-Tallaa, Véronique Bouvard, Franca Bianchini, Kurt Straif. N Engl J Med 2015
376
10



Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
Patricia A Carney, Diana L Miglioretti, Bonnie C Yankaskas, Karla Kerlikowske, Robert Rosenberg, Carolyn M Rutter, Berta M Geller, Linn A Abraham, Steven H Taplin, Mark Dignan,[...]. Ann Intern Med 2003
695
10

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
10

The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ.
A Francis, L Fallowfield, D Rea. Clin Oncol (R Coll Radiol) 2015
52
13

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Wendie A Berg, Zheng Zhang, Daniel Lehrer, Roberta A Jong, Etta D Pisano, Richard G Barr, Marcela Böhm-Vélez, Mary C Mahoney, W Phil Evans, Linda H Larsen,[...]. JAMA 2012
591
9

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
231
9

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
P A van Luijt, E A M Heijnsdijk, J Fracheboud, L I H Overbeek, M J M Broeders, J Wesseling, G J den Heeten, H J de Koning. Breast Cancer Res 2016
41
17

The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies.
Mireille Broeders, Sue Moss, Lennarth Nyström, Sisse Njor, Håkan Jonsson, Ellen Paap, Nathalie Massat, Stephen Duffy, Elsebeth Lynge, Eugenio Paci. J Med Screen 2012
234
9

Pan-Canadian study of mammography screening and mortality from breast cancer.
Andrew Coldman, Norm Phillips, Christine Wilson, Kathleen Decker, Anna M Chiarelli, Jacques Brisson, Bin Zhang, Jennifer Payne, Gregory Doyle, Rukshanda Ahmad. J Natl Cancer Inst 2014
132
9

Rethinking the Standard for Ductal Carcinoma In Situ Treatment.
Laura Esserman, Christina Yau. JAMA Oncol 2015
66
9

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
388
7

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Richard G Margolese, Reena S Cecchini, Thomas B Julian, Patricia A Ganz, Joseph P Costantino, Laura A Vallow, Kathy S Albain, Patrick W Whitworth, Mary E Cianfrocca, Adam M Brufsky,[...]. Lancet 2016
92
7

Molecular phenotypes of DCIS predict overall and invasive recurrence.
K E Williams, N L P Barnes, A Cramer, R Johnson, K Cheema, J Morris, M Howe, N J Bundred. Ann Oncol 2015
67
8

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.
M-F Yen, L Tabár, B Vitak, R A Smith, H-H Chen, S W Duffy. Eur J Cancer 2003
99
7

Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study.
Adriana M J Bluekens, Roland Holland, Nico Karssemeijer, Mireille J M Broeders, Gerard J den Heeten. Radiology 2012
88
7

Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program.
Per Skaane, Andriy I Bandos, Randi Gullien, Ellen B Eben, Ulrika Ekseth, Unni Haakenaasen, Mina Izadi, Ingvild N Jebsen, Gunnar Jahr, Mona Krager,[...]. Radiology 2013
577
7

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
232
7


Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.
Marc D Ryser, Mathias Worni, Elizabeth L Turner, Jeffrey R Marks, Rick Durrett, E Shelley Hwang. J Natl Cancer Inst 2015
38
15

MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
Christiane K Kuhl, Simone Schrading, Heribert B Bieling, Eva Wardelmann, Claudia C Leutner, Roy Koenig, Walther Kuhn, Hans H Schild. Lancet 2007
434
7


Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
202
7

Interpreting overdiagnosis estimates in population-based mammography screening.
Rianne de Gelder, Eveline A M Heijnsdijk, Nicolien T van Ravesteyn, Jacques Fracheboud, Gerrit Draisma, Harry J de Koning. Epidemiol Rev 2011
135
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.